Total Payments
$158,395
2024 Payments
$71,990
Companies
18
Transactions
194
Medicare Patients
1,073
Medicare Billing
$52,024
Payment Breakdown by Category
Consulting$79,725 (50.3%)
Other$47,355 (29.9%)
Travel$19,853 (12.5%)
Research$5,846 (3.7%)
Food & Beverage$4,980 (3.1%)
Education$636.35 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $79,725 | 20 | 50.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,145 | 8 | 23.5% |
| Travel and Lodging | $19,853 | 55 | 12.5% |
| Honoraria | $10,210 | 4 | 6.4% |
| Unspecified | $5,846 | 26 | 3.7% |
| Food and Beverage | $4,980 | 78 | 3.1% |
| Education | $636.35 | 3 | 0.4% |
Payments by Type
General
$152,550
168 transactions
Research
$5,846
26 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $77,145 | 95 | $0 (2024) |
| GlaxoSmithKline, LLC. | $32,343 | 21 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $10,052 | 13 | $0 (2017) |
| ABBVIE INC. | $9,144 | 11 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $7,440 | 12 | $0 (2022) |
| Ipsen Pharma SAS | $6,638 | 2 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $4,690 | 3 | $0 (2024) |
| Eli Lilly and Company | $3,080 | 6 | $0 (2019) |
| Siemens Medical Solutions USA, Inc. | $2,397 | 4 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,085 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $71,990 | 74 | Gilead Sciences, Inc. ($52,203) |
| 2023 | $27,556 | 32 | GlaxoSmithKline, LLC. ($13,701) |
| 2022 | $8,397 | 13 | Gilead Sciences, Inc. ($5,450) |
| 2020 | $2,066 | 2 | Theratechnologies Inc. ($2,066) |
| 2019 | $4,468 | 16 | Eli Lilly and Company ($2,421) |
| 2018 | $2,359 | 4 | Intercept Pharmaceuticals, Inc. ($1,626) |
| 2017 | $41,559 | 53 | Gilead Sciences Inc ($17,626) |
All Payment Transactions
194 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Honoraria | Cash or cash equivalent | $2,490.00 | General |
| Category: Rare Disease | ||||||
| 11/20/2024 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $550.00 | General |
| 11/20/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $403.10 | General |
| 11/20/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $288.95 | General |
| 11/20/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $120.00 | General |
| 11/20/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $120.00 | General |
| 11/20/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $48.80 | General |
| 11/20/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $41.12 | General |
| 11/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.41 | General |
| 11/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.00 | General |
| 11/20/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $8.60 | General |
| 11/19/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,790.00 | General |
| Category: INFLAM | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $39.03 | General |
| 11/17/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Rare Disease | ||||||
| 11/17/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $50.15 | General |
| 11/13/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Travel and Lodging | In-kind items and services | $494.00 | General |
| Category: INFLAM | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $101.40 | General |
| Category: INFLAM | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| 11/11/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Travel and Lodging | In-kind items and services | $45.56 | General |
| Category: INFLAM | ||||||
| 11/08/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,790.00 | General |
| Category: INFLAM | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $77.62 | General |
| Category: INFLAM | ||||||
| 11/05/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,440.00 | General |
| Category: INFLAM | ||||||
| 11/04/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Travel and Lodging | In-kind items and services | $988.00 | General |
| Category: INFLAM | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Travel and Lodging | In-kind items and services | $558.00 | General |
| Category: INFLAM | ||||||
| 10/10/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,440.00 | General |
| Category: INFLAM | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein | Takeda Pharmaceuticals U.S.A., Inc. | $2,085 | 13 |
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF-OF-CONCEPT STUDY EVALUATING THE EFFICACY AND SAFETY OF BARICITINIB (LY3009104) IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS WHO HAVE AN INADEQUATE RESPONSE OR ARE INTOLERANT TO UDCA | Eli Lilly and Company | $1,892 | 2 |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Subjects with Primary Sclerosing Cholangitis | Gilead Sciences, Inc. | $1,791 | 9 |
| A TWO-PART, RANDOMIZED, PLACEBO CONTROLLED, DOUBLE BLIND, MULTICENTER, | GlaxoSmithKline, LLC. | $53.75 | 1 |
| A PHASE IIB MULTI-CENTER, RANDOMISED, OPEN LABEL STUDY TO ASSESS THE E | GlaxoSmithKline, LLC. | $23.45 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 218 | 239 | $20,688 | $10,200 |
| 2022 | 3 | 288 | 308 | $24,933 | $11,657 |
| 2021 | 4 | 278 | 303 | $43,792 | $15,223 |
| 2020 | 4 | 289 | 308 | $47,843 | $14,945 |
Total Patients
1,073
Total Services
1,158
Medicare Billing
$52,024
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 74 | $8,150 | $5,252 | 64.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 20 | 28 | $3,035 | $2,078 | 68.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $3,638 | $1,999 | 55.0% |
| 91200 | Measurement of liver stiffness | Facility | 2023 | 74 | 74 | $3,774 | $589.69 | 15.6% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 40 | 41 | $2,091 | $280.57 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 73 | $8,140 | $5,399 | 66.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $4,798 | $3,039 | 63.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 18 | 25 | $2,815 | $1,809 | 64.3% |
| 91200 | Measurement of liver stiffness | Facility | 2022 | 132 | 132 | $6,732 | $1,013 | 15.1% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 46 | 48 | $2,448 | $396.57 | 16.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 80 | $9,065 | $6,091 | 67.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $4,330 | $2,928 | 67.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $11,520 | $2,866 | 24.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 22 | 29 | $3,235 | $2,115 | 65.4% |
| 91200 | Measuring the stiffness in the liver via elastography | Office | 2021 | 74 | 76 | $7,980 | $613.03 | 7.7% |
| 91200 | Measuring the stiffness in the liver via elastography | Facility | 2021 | 74 | 74 | $7,662 | $609.70 | 8.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 63 | 74 | $7,102 | $4,473 | 63.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 44 | 52 | $4,800 | $2,959 | 61.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 22 | 22 | $3,941 | $2,427 | 61.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 14 | 14 | $8,960 | $2,375 | 26.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 18 | 18 | $2,688 | $1,400 | 52.1% |
| 91200 | Measuring the stiffness in the liver via elastography | Office | 2020 | 66 | 66 | $10,494 | $665.17 | 6.3% |
| 91200 | Measuring the stiffness in the liver via elastography | Facility | 2020 | 62 | 62 | $9,858 | $645.43 | 6.5% |
About Dr. Stuart Gordon, M.D
Dr. Stuart Gordon, M.D is a Gastroenterology healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679641112.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Gordon, M.D has received a total of $158,395 in payments from pharmaceutical and medical device companies, with $71,990 received in 2024. These payments were reported across 194 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($79,725).
As a Medicare-enrolled provider, Gordon has provided services to 1,073 Medicare beneficiaries, totaling 1,158 services with total Medicare billing of $52,024. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Detroit, MI
- Active Since 12/01/2006
- Last Updated 08/07/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1679641112
Products in Payments
- Livdelzi (Drug) $43,029
- OCA (Drug) $5,774
- Viekira (Drug) $3,022
- IQIRVO (Drug) $2,615
- OCALIVA (Drug) $1,667
- XIFAXAN (Drug) $802.55
- Doptelet (Drug) $132.00
- Varithena Administration Pack (Device) $88.71
- EGRIFTA (Drug) $66.36
- Vemlidy (Drug) $66.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Detroit
Dilip Moonka, M.d, M.D
Gastroenterology — Payments: $782,250
Gastroenterology $782,250
Dr. Syed-Mohammed Jafri, M.d, M.D
Gastroenterology — Payments: $511,801
Gastroenterology $511,801
Milton Mutchnick, Md, MD
Gastroenterology — Payments: $197,024
Gastroenterology $197,024
Dr. Juan Reyes Genere, Md, MD
Gastroenterology — Payments: $36,160
Gastroenterology $36,160
Humberto Gonzalez Gonzalez, M.d, M.D
Gastroenterology — Payments: $27,255
Gastroenterology $27,255
Mark Blumenkehl, M.d, M.D
Gastroenterology — Payments: $1,786
Gastroenterology $1,786